Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd.
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2018.
| 1. autor: | |
|---|---|
| Kolejni autorzy: | |
| Format: | Internship report |
| Język: | English |
| Wydane: |
BRAC University
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | http://hdl.handle.net/10361/11092 |
| id |
10361-11092 |
|---|---|
| record_format |
dspace |
| spelling |
10361-110922019-09-30T04:48:55Z Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. Islam, Md. Saiful Billah, N.M. Baki BRAC Business School, BRAC University GlaxoSmithKline Bangladesh Limited Pharmaceuticals This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2018. Cataloged from PDF version of internship report. Includes bibliographical references (page 40-41). The pharmaceutical industry in Bangladesh has been increasing in recent years and currently, the market stands at 142 billion BDT. Demand for good quality drugs is on the rise and the local market demand will to reach BD 160 billion BDT by 2018. Bangladesh pharmaceutical companies supply generic products and can charge premiums for their products. The top 10 companies have about 67% of the market. It is very complicated to enter this sector due to a high investment. GlaxoSmithKline Bangladesh Ltd is one of the renowned pharmaceutical company, listed on the Dhaka Stock Exchange, and has been successful in the stock market. The company has a very high dividend payment rate that primarily attracts the company's shareholders. The profitability of this company declined from 2016 to 2017. The company has a very low current ratio that could pose a threat to it. Therefore, the company should focus more on this problem and should be careful to monitor the debts. Although, after comparing the financial report with other pharmaceuticals found that GSK had a good financial performance because of the performance of their consumer health sector. On the other hand, sales of the pharmaceutical unit are shrinking as they could not cope up with the rivals and failure to match the current market demand leads to a decrease in sales. Therefore, that may lead their pharmaceutical business unsustainable. The pharmaceutical unit is incurring losses for the last three years consecutively. Hence, the GSK shareholders and board of directors decide to close the pharmaceutical business unit and continue their operation in Bangladesh with consumer healthcare business, which is profitable. Therefore, the aims are to identify the factors that influence GSK Bangladesh Ltd. to close down its pharmaceutical business unit in Bangladesh although the industry is growing at 15% more than GDP growth rate of the country. It also focuses on the processes that need to give attention as a multinational pharmaceutical company while existing from Bangladeshi market. Md. Saiful Islam B. Business Administration 2019-01-09T05:29:25Z 2019-01-09T05:29:25Z 2018 2018-12 Internship report ID 16104124 http://hdl.handle.net/10361/11092 en BRAC University Internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 45 pages application/pdf BRAC University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
GlaxoSmithKline Bangladesh Limited Pharmaceuticals |
| spellingShingle |
GlaxoSmithKline Bangladesh Limited Pharmaceuticals Islam, Md. Saiful Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. |
| description |
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2018. |
| author2 |
Billah, N.M. Baki |
| author_facet |
Billah, N.M. Baki Islam, Md. Saiful |
| format |
Internship report |
| author |
Islam, Md. Saiful |
| author_sort |
Islam, Md. Saiful |
| title |
Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. |
| title_short |
Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. |
| title_full |
Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. |
| title_fullStr |
Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. |
| title_full_unstemmed |
Factors behind exiting from the Bangladesh pharmaceutical industry and closing down the pharma businesses unit of GlaxoSmithKline Bangladesh Ltd. |
| title_sort |
factors behind exiting from the bangladesh pharmaceutical industry and closing down the pharma businesses unit of glaxosmithkline bangladesh ltd. |
| publisher |
BRAC University |
| publishDate |
2019 |
| url |
http://hdl.handle.net/10361/11092 |
| work_keys_str_mv |
AT islammdsaiful factorsbehindexitingfromthebangladeshpharmaceuticalindustryandclosingdownthepharmabusinessesunitofglaxosmithklinebangladeshltd |
| _version_ |
1814307782900318208 |